Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) is scheduled to present at the upcoming BMO Capital Markets 9th Annual Focus
on Healthcare Conference at the Millennium Broadway Hotel in New York City on Wednesday, August 5, 2009 at 1:45 p.m. ...
FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business
MADISON, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to the...
Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced a strategic restructuring to focus
its operations on the development of ANA598, in particular a proposed Phase II study in hepatitis C patients of ANA598 in combination with pegylated int...
New Stem Cell Web Site to Focus on Traumatic Brain Injury, Spinal Cord Injury and Diabetes
SAN DIEGO, May 28 /PRNewswire/ -- Entest BioMedical, Inc., a newly formed wholly-owned subsidiary of San Diego-based Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) announced today the launch of its Web site ( http://www.EntestBio.com ) to focus
on new stem cell research, includin...
Sixth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Chronic Care Management & Wellness Promotion
ROLLING HILLS ESTATES, Calif., May 7 /PRNewswire/ -- The Sixth Annual Healthcare Unbound Conference & Exhibition, organized by The Center for Business Innovation (TCBI), will feature the coming together of consumer and healthcare technologies to facilitate participatory medicine . The Conf...
Health Strategies Group Expands Focus of Pharma Sales Force Effectiveness Service Under New Vision and Name
Strategic Selling Outlook Addresses Rapidly Changing Selling Environment and Future Needs of Physicians and Sales Representatives
LAMBERTVILLE, N.J., April 16 /PRNewswire/ -- Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industrie...
Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline
PALO ALTO, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) announced today that it is implementing a reorganization to focus
on its most advanced preclinical and clinical drug development programs. The reorganization will enable the company to continue the developme...
'Enrichment of Genomic Loci for Targeted Sequencing Application' Is Focus of 2009 AGBT Conference Workshop
LEXINGTON, Mass., Jan. 30 /PRNewswire/ -- Jeff Olson, Manager of Nucleic Acid Applications, of RainDance Technologies, Inc., will present " Enrichment of Genomic Loci for Targeted Sequencing Applications , " to explain application of the RainStorm micro-droplet technology on the new RDT 1000 in...
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
MOUNTAIN VIEW, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Alexza
Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it has consolidated
its operations, with a primary focus
on the continued rapid development of
AZ-004 (Staccato loxapine). The restructuring includes a workforce reduct...
Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program
SAN FRANCISCO, Jan. 20 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), today announced that it will focus
resources on the development of its natriuretic peptide franchise, including CD-NP which is in Phase II development for acute heart failure, and CU-NP which is a pre-clini...
Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22
BOSTON, Jan. 13 /PRNewswire/ -- Responding to the increased risk to
patient safety in an economic downturn, the National Patient Safety Foundation
has announced that the 2009 NPSF Patient Safety Congress will directly address
this issue through an extensive program of educational sessions desi...
'Biology in Pico-Liter Droplets' is Focus of Presentation at LabAutomation 2009
LEXINGTON, Mass., Jan. 12 /PRNewswire/ -- Darren R. Link, Ph.D., of RainDance Technologies, Inc., will present " Biology in Pico-Liter Droplets, " a discussion of the commercialization of the use of picoliter droplets in microfluidic channels for applications in the life sciences, at the LabAuto...
Nikon Instruments Perfect Focus System Wins Second Place in The Scientist's Top Innovations of 2008 Award
MELVILLE, N.Y., Dec. 15 /PRNewswire/ -- A panel of expert judges selected Nikon Instruments, Inc.'s ( www.nikoninstruments.com ) Ti-E Perfect Focus
System (PFS) as second place among the top ten in The Scientist's Top Innovations of 2008 Award, which recognizes winning combinations of invention,...
GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research
NEW ROCHELLE, N.Y., Dec. 4 /PRNewswire/ -- Researchers are taking a closer look at the phosphoinositide 3-kinase (PI3-kinase) pathway as studies continue to demonstrate that inhibiting this biological route suppresses tumor growth, reports Genetic Engineering & Biotechnology News (GEN) . The ...
WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
SHANGHAI, China, Dec. 2 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.
(NYSE: WX ), a leading pharmaceutical, biotechnology and medical device
research and development outsourcing company with operations in China and the
United States, today announced it will dedicate its Philadelphia facili...
Arpida to Restructure and Focus on Key Projects
REINACH, Switzerland, November 27 /PRNewswire-FirstCall/ -- Arpida
announced today that it is refocusing all projects and priorities around the
key strategic asset Iclaprim. The company says this is to be seen as a
consequence of the negative recommendation of the U.S. Food and Drug
Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
SAN DIEGO, Nov. 13 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals,
Inc. (Nasdaq: ANDS ) announced today that it will present at the Needham &
Company, LLC's Focus
on Infectious Disease Conference on Thursday, November
20, 2008 at 10:00 a.m. EST (7:00 a.m. PST) at the Needham and Company,
GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C
PHILADELPHIA, Oct. 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:
GSK) (LSE: GSK) and Genelabs Technologies, Inc. (Nasdaq: GNLB ) announced
today that they have entered into a definitive agreement pursuant to which
GSK will acquire Genelabs for approximately $57 million (pounds Sterling ...
Isolagen to Present at the JMP Securities Healthcare Focus Conference
EXTON, Pa., Oct. 3 /PRNewswire-FirstCall/ -- Isolagen, Inc. (Amex: ILE )
announced today that Declan Daly, Chief Executive Officer, will present at
the JMP Securities Healthcare Focus
Conference on Monday, October 6, 2008
at 3:30 p.m. (EST) at Le Parker Meridien hotel in New York, New York.
ARCA biopharma to Present at JMP Securities Healthcare Focus Conference
Webcast Presentation Scheduled for Monday, October 6, 2008 at 3:00 p.m. EDT
BROOMFIELD, Colo., Oct. 2 /PRNewswire/ -- ARCA biopharma, Inc., a
biopharmaceutical company developing genetically-targeted therapies for
heart failure and other cardiovascular diseases, today announced that
Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
SKOKIE, Ill., Oct. 1 /PRNewswire/ -- Horizon Therapeutics, Inc., a
privately held biopharmaceutical company, announced today that Timothy P.
Walbert, president and chief executive officer, will present a corporate
overview at the JMP Securities Healthcare Focus
Conference in New York on
BioCryst to Present at the JMP Healthcare Focus Conference
BIRMINGHAM, Ala., Oct. 1 /PRNewswire-FirstCall/ -- BioCryst
Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced that Jon P.
Stonehouse, Chief Executive Officer and President of BioCryst, will present
a corporate update at the JMP Healthcare Focus
Conference in New York on
Monday, October 6,...
Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
PRINCETON, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Pharmasset, Inc.
(Nasdaq: VRUS ) management will present at the Third Annual JMP Securities
Conference being held from October 6-7, 2008 at the Le
Parker Meridien in New York City. Schaefer Price, Pharmasset's Chief
NxStage Medical to Present at JMP Securities Healthcare Focus Conference
LAWRENCE, Mass., Sept. 30 /PRNewswire-FirstCall/ -- NxStage Medical,
Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis
products, today announced that Jeffrey H. Burbank, Chief Executive Officer,
and Robert S. Brown, Chief Financial Officer, will be presenting at the JMP
Genomic Health to Present at JMP Securities Healthcare Focus Conference
REDWOOD CITY, Calif., Sept. 30 /PRNewswire-FirstCall/ -- Genomic
Health, Inc. (Nasdaq: GHDX ) today announced that Kim Popovits, Genomic
Health's President and Chief Operating Officer, will present at the JMP
Securities Healthcare Focus
Conference in New York on Tuesday, October 7,
2008 at 10...
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference
SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals,
Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing,
developing and commercializing proprietary product candidates principally
for use in the hospital setting, announced today that the company's
Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
SOUTH SAN FRANCISCO, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Poniard
Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused
on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO,
will present at the JMP Securities Healthcare Focus
Conference on Monday...
Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals
MUNICH, Germany, Sept. 29 /PRNewswire/ -- NOMAD Bioscience GmbH,
Munich, Germany (NOMAD) is a private biotechnology company developing
plant-made biomaterials and biopharmaceuticals that address critical unmet
needs. NOMAD is developing a series of high-value products such as
2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expo's 14-Year History
NEW YORK, Sept. 17 /PRNewswire/ -- The 14th Annual National Ergonomics
Conference and Exposition (NECE) at Caesars Palace, Las Vegas, Dec. 2-5,
will feature a record number of conference sessions, and mark the debut of
four new tracks of conference programming geared toward workplace design
Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
SAN DIEGO, Sept. 17 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc.
(Nasdaq: RDEA ) announced today that Barry D. Quart, PharmD, President and
CEO of Ardea Biosciences, will present at two upcoming investor
UBS Global Life Sciences Conference
Date: Wednesday, September ...
Atrial Fibrillation Month - StopAfib.org Announces September Focus on Life-Threatening Irregular Heartbeat
DALLAS, Sept. 2 /PRNewswire/ -- StopAfib.org, at
http://www.StopAfib.org, announces that September is Atrial Fibrillation
Month to raise awareness of this life-threatening irregular heartbeat,
commonly called afib or AF.
Once considered benign, this common cardiac arrhythmia can often lead...
Pipeline for Breast Cancer Therapies is Focus of New MedPredict Report
SCOTTSDALE, Ariz., Aug. 27 /PRNewswire/ -- MedPredict has published a
new report in its oncology series entitled "Thought Leader Insight &
Analysis: Breast Cancer," designed to provide critical strategic insight
for pharma and biotech companies with a stake in the market for diagnostics
Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV
Report: Hundreds of Studies Show that Programs to Curb Unsafe Sex and Drug
Use are Highly Effective, but Often Overlooked in Global AIDS Response
MEXICO CITY, Aug. 5 /PRNewswire/ -- In a new report released today, an
international panel of AIDS experts calls on global leaders to aggressively...
Bionovo to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
EMERYVILLE, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Bionovo, Inc.
(Nasdaq: BNVI ), a pharmaceutical company focused on the discovery and
development of safe and effective drugs in the areas of women's health and
cancer, announced today that Tom Chesterman, SVP and CFO of Bionovo, will
Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
SAN FRANCISCO, Aug. 1 /PRNewswire-FirstCall/ -- Medivation, Inc.
(Nasdaq: MDVN ) today announced that David Hung, M.D., president and chief
executive officer, will present at the BMO Capital Markets 2008 Focus
Healthcare Conference on Tuesday, August 5, at 11:15 a.m. Eastern Time at
Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
RICHMOND, Calif., July 29 /PRNewswire-FirstCall/ -- Sangamo
BioSciences, Inc. (Nasdaq: SGMO ) announced today that Edward Lanphier,
Sangamo's president and CEO, will provide an update on the progress of
Sangamo's ZFP Therapeutic development programs and an overview of the
company's business s...
VNUS Medical Technologies to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
SAN JOSE, Calif., July 28 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS ), a leading provider of medical devices
for the minimally invasive treatment of venous reflux disease, today
announced its plans to present at the BMO Capital Markets 2008 Focus
Joint nanotechnology forum to focus on electronics, photonics, renewable energy
Applications of nanotechnology to electronics, photonics and renewable energy will be the focus
of a joint forum to be held from August 10 to 14, 2009 at McMaster University in Hamilton, Ontario, Canada. An innovation workshop will also be presented in conjunction with the event.
The 4th Nano ...
Fifth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Disease Management & Wellness Promotion
ROLLING HILLS ESTATES, Calif., June 19 /PRNewswire-USNewswire/ -- The
Fifth Annual Healthcare Unbound Conference and Exhibition, hosted by The
Center for Business Innovation (TCBI), will feature the coming together of
consumer and healthcare technologies to promote wellness and to help manage
South Palm Orthospine Institute Now Open: World Renowned Orthopedic Specialist and Author, Stewart G. Eidelson, Announced the New Practice with a Focus on Spine and Spinal Stenosis
Founder of SpineUniverse.com and South Florida Spinal Stenosis Foundation,
the internationally acclaimed surgeon presents the new state-of-the-art
research, technology and treatment centers in Delray, Boynton Beach & Boca Raton.
BOYNTON BEACH, Fla., June 6 /PR...